Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)

The present application discloses oxadiazole based compounds of Formula (I) active on sphingosine-1-phosphate (S1P) in particular useful to treat lupus erythematosus. A is phenyl or a 5 or 6-membered heteroaryl ring; R

Saved in:
Bibliographic Details
Main Authors JOHNSON, CHRISTOPHER NORBERT, SKIDMORE, JOHN, DEMONT, EMMANUEL HUBERT, HEER, JAG PAUL, HURST, DAVID NIGEL, WALL, IAN DAVID, WITHERINGTON, JASON, HEIGHTMAN, THOMAS DANIEL
Format Patent
LanguageEnglish
Published 26.09.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present application discloses oxadiazole based compounds of Formula (I) active on sphingosine-1-phosphate (S1P) in particular useful to treat lupus erythematosus. A is phenyl or a 5 or 6-membered heteroaryl ring; R
Bibliography:Application Number: AU20080339988